Publication | Open Access
Direct Activation of Cyclin-Dependent Kinase 2 by Human Papillomavirus E7
70
Citations
47
References
2003
Year
Hpv ReplicationSignal TransductionHuman Papillomavirus VaccinesReceptor Tyrosine KinaseImmunologyRetinoblastoma ProteinPathologyMolecular BiologyMolecular BasisE7 PeptidesMedicineCell BiologyCell SignalingDirect ActivationTumor BiologyViral OncologyCancer-associated Virus
Addition of human papillomavirus (HPV) E7 CDK2/cyclin A or CDK2/cyclin E, purified from either insect cells or bacteria, dramatically upregulates histone H1 kinase activity. Activation is substrate specific, with a smaller effect noted for retinoblastoma protein (Rb). The CDK2 stimulatory activity is equivalent in high-risk (HPV type 16 [HPV16] and HPV31) and low-risk (HPV6b) E7. Mutational analyses of HPV16 E7 indicate that the major activity resides in amino acids 9 to 38, spanning CR1 and CR2, and does not require casein kinase II or Rb-binding domain functions. Synthetic peptides spanning HPV16 amino acid residues 9 to 38 also activate CDK2. Peptides containing this sequence that carry biotin on the carboxy terminus, as well as a photoactivated cross-linking group (benzophenone), also activate the complex and covalently associate with the CDK2/cyclin A complex in a specific manner requiring UV. Cross-linking studies that use protein monomers detect association of the E7 peptides with cyclin A but not CDK2. Together, our results indicate a novel mechanism whereby E7 promotes HPV replication by directly altering CDK2 activity and substrate specificity.
| Year | Citations | |
|---|---|---|
1970 | 251K | |
1976 | 225.3K | |
1976 | 209.3K | |
2013 | 47.3K | |
1990 | 4K | |
1989 | 3K | |
1990 | 2.6K | |
1999 | 1.1K | |
1997 | 925 | |
2000 | 668 |
Page 1
Page 1